- Report
- April 2024
- 185 Pages
Global
From €4121EUR$4,500USD£3,509GBP
- Report
- October 2023
- 70 Pages
Egypt
From €3205EUR$3,500USD£2,729GBP
- Report
- October 2023
- 190 Pages
Global
From €4121EUR$4,500USD£3,509GBP
From €3205EUR$3,500USD£2,729GBP
- Report
- February 2023
- 79 Pages
Saudi Arabia
From €3205EUR$3,500USD£2,729GBP
- Report
- April 2023
- 110 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- August 2022
- 112 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- August 2022
- 120 Pages
Global
From €4350EUR$4,750USD£3,704GBP
- Report
- September 2024
- 82 Pages
India
From €3205EUR$3,500USD£2,729GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4533EUR$4,950USD£3,860GBP
- Report
- February 2024
- 200 Pages
Global
From €4442EUR$4,850USD£3,782GBP
- Report
- March 2024
- 200 Pages
Global
From €3801EUR$4,150USD£3,236GBP
- Report
- March 2024
- 200 Pages
Global
From €3801EUR$4,150USD£3,236GBP
- Report
- September 2023
- 143 Pages
Global
From €4075EUR$4,450USD£3,470GBP
- Report
- January 2023
- 220 Pages
Global
From €4075EUR$4,450USD£3,470GBP
- Report
- December 2022
- 122 Pages
North America
From €3160EUR$3,450USD£2,690GBP
- Report
- December 2022
- 137 Pages
Europe
From €3160EUR$3,450USD£2,690GBP
- Report
- September 2022
- 202 Pages
Global
From €4075EUR$4,450USD£3,470GBP
- Report
- August 2022
- 236 Pages
From €3160EUR$3,450USD£2,690GBP
- Report
- August 2022
- 245 Pages
North America
From €3160EUR$3,450USD£2,690GBP

The Respiratory Disease market within the context of Pulmonary Medicine is a broad field of study that focuses on the diagnosis, treatment, and prevention of diseases that affect the lungs and airways. This includes conditions such as asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, and pulmonary hypertension. Treatment options for these conditions range from lifestyle modifications to medications, and in some cases, surgery. Research in this field is ongoing, with the aim of improving the quality of life for those affected by respiratory diseases.
Companies in the Respiratory Disease market include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, Novartis, and Pfizer. These companies are involved in the development of new treatments and therapies for respiratory diseases, as well as the manufacture and distribution of existing treatments. Show Less Read more